These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9031106)

  • 1. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
    Jotterand M; Parlier V
    Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome 17 abnormalities in patients with primary myelodysplastic syndrome: incidence and biologic significance].
    Marisavljević D; Rolović Z; Panitić M; Novak A; Djordjević V; Lazarević V; Bosković D; Colović M
    Srp Arh Celok Lek; 2004; 132(1-2):10-3. PubMed ID: 15227958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
    Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
    Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
    Mecucci C
    Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
    Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
    Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes.
    Schmetzer HM; Poleck B; Duell T; Gerhartz HH; Mittermüller J
    Ann Hematol; 2000 Jan; 79(1):20-9. PubMed ID: 10663617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
    Suciu S; Kuse R; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
    Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
    Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
    Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
    Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
    Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal abnormalities in primary myelodysplastic syndrome.
    Rashid A; Khurshid M; Shaikh U; Adil S
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
    Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
    Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic findings in primary and secondary MDS.
    Heim S
    Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
    Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
    Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.